Mayinglong Pharmaceutical Group Co Ltd
600993
Company Profile
Business description
Mayinglong Pharmaceutical Group Co Ltd is a China-based company mainly involved in pharmaceutical development, retailing and wholesaling. The company provides ointments, suppositories, and tablets for hemorrhoids.
Contact
No. 100 Zhoujiawan
Nanhu
Wuchang District
WuhanHubei430064
CHNT: +86 2787389583
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
2,654
Stocks News & Analysis
stocks
Investors punish this ASX player after acquisition
We think the floundering stock price is not reflective of underlying asset value.
stocks
Revenue growth on track for undervalued ASX healthcare stock
Near-term cost growth does not change our long-term view.
stocks
Sales shine but broader macro outlook darkens for this ASX share
US stores are struggling, but our investment thesis hinges on the Australian rollout.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,155.80 | 34.00 | 0.37% |
| CAC 40 | 8,267.90 | 22.11 | 0.27% |
| DAX 40 | 23,869.26 | 62.27 | 0.26% |
| Dow JONES (US) | 48,042.66 | 143.14 | -0.30% |
| FTSE 100 | 10,603.66 | 0.18 | 0.00% |
| HKSE | 25,893.54 | 141.14 | 0.55% |
| NASDAQ | 22,981.87 | 159.45 | 0.70% |
| Nikkei 225 | 56,924.11 | 1,028.79 | 1.84% |
| NZX 50 Index | 13,181.44 | 92.37 | -0.70% |
| S&P 500 | 6,837.65 | 12.99 | 0.19% |
| S&P/ASX 200 | 8,960.60 | 36.20 | 0.41% |
| SSE Composite Index | 3,986.22 | 20.05 | 0.51% |